BeschrijvingTET-mediated DNA modifications and demethylation.png
FIGURE 1. TET-mediated DNA modifications and demethylation. (A) Unmodified cytosine (C) is methylated by DNA methyltransferases (DNMTs) at the 5 position to become 5-methylcytosine (5mC). TET proteins oxidize 5mC into 5-hydroxymethylcytosine (5hmC), a stable epigenetic mark, and subsequently to 5-formylcytosine (5fC) and 5-carboxylcytosine (5caC). TET can demethylate DNA via replication-dependent (passive) or replication-independent (active) mechanisms. (B) Left, passive DNA demethylation. DNMT1/UHRF1 complex recognizes 5mC at the hemi-methylated CpG motif during DNA replication and methylates the unmodified cytosine on the newly synthesized DNA strand (left; pink strand). However, the oxidized ethylcytosines 5hmC, 5fC, and 5caC (together, oxi-mC) are not recognized by DNMT1/UHRF1, resulting in unmodified cytosine on the new DNA strand. Further DNA replication in the presence of continuing TET activity will result in progressive dilution of 5mC in the daughter cells. Right panel, active DNA demethylation. While 5hmC is stable and persists in the genome, 5fC and 5caC can be recognized and excised by thymine DNA glycosylase (TDG), and the resulting abasic sites are repaired as unmodified C by base excision repair (BER). Other mechanisms (e.g., decarboxylation of 5caC) have been suggested but have not yet been proven to exist. (C) The approximate abundance of unmodified and modified cytosines in the haploid human/mouse genome. About 5% of cytosine is methylated (5mC); in most cells, the vast majority of 5mC is present at CG dinucleotides although it is low at
CpG islands. 5hmC amounts to about 1-10% of 5mC (estimated at 10% here as in embryonic stem cells), while the levels of 5fC and 5caC are each about an order of magnitude lower than the previous oxidative modification. It is not known whether the low levels of 5fC and 5caC are due to features of TET enzymes that cause them to arrest at 5hmC, or to their continuing removal by TDG or other mechanisms.
Enzymes and 5hmC in Adaptive and Innate Immune Systems. Front. Immunol. 10:210 doi: 10.3389/fimmu.2019.00210
Auteur
Lio C-WJ and Rao A
Dit bestand, dat oorspronkelijk toegevoegd was op een externe website, is nog niet beoordeeld door een moderator of reviewer om te bevestigen dat de opgegeven licentie geldig is. Zie Category:License review needed voor meer instructies.
Delen – het werk kopiëren, verspreiden en doorgeven
Remixen – afgeleide werken maken
Onder de volgende voorwaarden:
naamsvermelding – U moet op een gepaste manier aan naamsvermelding doen, een link naar de licentie geven, en aangeven of er wijzigingen in het werk zijn aangebracht. U mag dit op elke redelijke manier doen, maar niet zodanig dat de indruk wordt gewekt dat de licentiegever instemt met uw werk of uw gebruik van zijn werk.
https://creativecommons.org/licenses/by/4.0CC BY 4.0 Creative Commons Attribution 4.0 truetrue
Bijschriften
Beschrijf in één regel wat dit bestand voorstelt
Items getoond in dit bestand
beeldt af
auteursrechtenstatus
auteursrechtelijk beschermd
licentie
CC BY 4.0
datum van oprichting of creatie
12 feb 2019
Bestandsgeschiedenis
Klik op een datum/tijd om het bestand te zien zoals het destijds was.
{{Information |description= FIGURE 1. TET-mediated DNA modifications and demethylation. (A) Unmodified cytosine (C) is methylated by DNA methyltransferases (DNMTs) at the 5 position to become 5-methylcytosine (5mC). TET proteins oxidize 5mC into 5-hydroxymethylcytosine (5hmC), a stable epigenetic mark, and subsequently to 5-formylcytosine (5fC) and 5-carboxylcytosine (5caC). TET can demethylate DNA via replication-dependent (passive) or replication-independent (active) mechanisms. (B) Left, pas...
Bestandsgebruik
Dit bestand wordt op de volgende 2 pagina's gebruikt: